Biotech

Chicago-based Tempus, which uses AI for drug discovery, clinical trials, and diagnostics, raised $275M in equity and debt, bringing its total funding to $1.3B+

This is not your average raise.  —  Biotech upstart Tempus announced on Thursday it raised $275 million through equity …